Improving Intermediate Risk Management. MARK Study "MARK"

Active, not recruiting

Phase N/A Results N/A

Summary of Purpose

Cardiovascular risk functions fail to identify more than 50% of patients who develop cardiovascular disease. This is especially evident in the intermediate-risk patients in which clinical management becomes difficult. The purpose of this study is to analyze if ankle-brachial index (ABI), measures of arterial stiffness, postprandial glucose, glycosylated hemoglobin, self-measured blood pressure and presence of...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 8 September 2016.

1 Jul 2011 31 Aug 2011 1 Dec 2013 1 Dec 2016 1 Sep 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Probability Sample

Contacts